<span item_type="fundamental" item_id="dc2f0bff4bf9c091d92a19e1657eb9ff" counter_id="ST/US/ATMCR" env="prod"></span><span item_type="announcement" item_id="584264802792640897" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 0.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -163.26 K.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not generated any operating revenues as of September 30, 2025, and will not generate any until the completion of its initial business combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>For the three months ended September 30, 2025, the company reported a net income of $165,713, which includes income of $1,227 from formation and operating costs offset by income earned on investment held in Trust Account of $164,486.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li><li>For the nine months ended September 30, 2025, the company reported a net income of $156,367, which includes a loss of $472,179 from formation and operating costs offset by income earned on investment held in Trust Account of $628,546.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>As of September 30, 2025, the company had a cash balance of $1,281 and a working capital deficit of $3,941,880.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li><li>Net cash provided by operating activities for the nine months ended September 30, 2025, was $154,795.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li><li>Net cash used in investing activities for the nine months ended September 30, 2025, was - $154,939.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>The company has investments held in a Trust Account amounting to $16,023,769 as of September 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to complete a business combination and has extended the deadline multiple times, with the latest extension allowing up to October 4, 2025. The company has entered into a merger agreement with HCYC Group Company Limited, which is expected to be consummated after obtaining the required approvals.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li><li><strong>Non-Core Business</strong>: The company has entered into Securities Purchase Agreements with accredited investors for a PIPE Financing of $11.5 million, which is expected to close concurrently with the business combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1889106/000149315225024097/form10-q.htm"></span></li></ul>

ALPHATIME ACQUISITION CORP ORD USD0.0001 (SUB/RIGHTS) | 10-Q: FY2025 Q3 Revenue: USD 0